New solutions and opportunities for 21ST century companies

LISBON INVESTOR CONFERENCE

Lisboa is currently at the heart of the innovation and entrepreneurship ecosystem, supported by highly skilled and motivated companies, professionals and educational institutions.

The first day of the conference is promoted by the Family Businesses Association. Called Growth Day, it will address the theme of finance to companies, traditional solutions vs. new alternatives.

The second day will be promoted by Hovione Capital. Called Health Startup Day, it will be dedicated to startups and investors focused on health care innovation.

When?

November 7th and 8th

Museum of the Orient, Lisbon

Learn more about the

Agenda

Thursday November 7th

GROWTH DAY

09h00 |

Registration, Networking and Welcome Coffee

09h30 |

Opening time
Peter Villax, Conference Host and President of the Portuguese Family Business Association
Marcos Lagoa, Conference Chairman

09h40 |

Keynote Session: The importance of capital markets for Portugal.
Minister of the Economy (tbc)

10h00 |

Masterclass: Financing alternatives and the Advisory Role
José Lemos, Partner, Clearwater International
Rita Barosa, CEO, Alantra Portugal

10h30 |

Coffee Break and Networking

11h00 |

Debt – The Classic Alternative
Case Study: Alantra Private Debt

11h45 |

Mezzanine – Boosting Growth
Gonçalo Mendes e Daniel Viana, Oxy Capital
Case Study – Respol

12h20 |

Private Equity – New shareholders to Growth
Marco Lebre, Partner, Crest Capital Partners
João Coelho Borges, Partner, Magnum Capital Industrial Partners

Case Study: Solzaima with Nuno Cerqueira

13h30 |

Buffet Lunch and Networking

14h00 |

Taxes – The Eternal Variable
Michael A. Santos, KPMG

14h45 |

Masterclass: Corporate Governance – Governing the Family and the Business
Duarte Pitta Ferraz, Nova SBE
João Talone, Partner Magnum Capital Industrial Partners

15h15 |

Round Table: Corporate Governance

Moderator: Duarte Pitta Ferraz

João Talone, Magnum Capital Industrial Partners

15h30 |

Coffee Break and Networking

15h45 |

Interview with Diane Villax, Hovione
By Alexandra Abreu Loureiro, partner of the reputational consultant Brunswick Group

16h30 |

Closure: Conference
Conclusions by Peter Villax

16h40 |

Drinks & Networking

19h40 |

Lisbon Investor Conference Dinner at Kais Restaurant
Keynote Speaker: Garrett McNamara, surfer of the great wave of the Nazareth Cannon.
Ingredients for success: courage, preparation and teamwork.

The speakers

Diane

Villax

Diane Villax is Founder Chairman of Hovione, a company she founded in 1959 with her husband, Ivan Villax. Hovione is a worldwide company with a large experience in the development and compliant manufacture of Active Pharmaceutical Ingredients and Drug Product Intermediates.

Garrett

McNamara

Garrett McNamara is a giant wave explorer, renowned for discovering and pioneering when surfing the world’s largest wave in Nazareth. Since then he has shared his experience as a leader.

Pedro

Siza Vieira

Pedro Siza Vieira is a Portuguese lawyer and politician. From October 2017 to October 2018 he was Minister Assistant to the Prime-Minister, and he is currently, Assistant Minister to the Prime-Minister and Minister of Economy of the Portuguese Government.

Alexandra

Abreu Loureiro

Alexandra Abreu Loureiro is partner at the Brunswick Group, a reputation consulting group which leads in Portugal and in the Portuguese-speaking world.

Interested?

View the agenda | Buy Tickets

Learn more about the

Agenda

Friday. November 8th

HEALTH STARTUP DAY

08h00 |

Registration, Networking and Welcome Coffee

09h00 |

Opening of the Conference
Welcome Remarks – Peter Villax, Chairman Hovione Capital
Conference Outline – Ricardo P. Henriques, Conference Chairman & CEO Hovione Capital

09h20 |

Keynote Session: Why this is a great time to invest in life sciences in Portugal.
Carlos Moedas, European Commissioner for Research, Science and Innovation (tbc)

09h40 |

Therapeutics Time: Presentations by SolasCure, Immunethep and CellmAbs

10h30 |

Coffee Break and Networking

11h00 |

Therapeutics Time: Presentations by BSIM Therapeutics and Asgard Therapeutics

Jury Members
Lev Osherovich, Versant Ventures (CH)
Daniela Couto, Biogeneration (NL)
Giovanni Mariggi, Medicxi (UK)
Jonathan Tobin, Arix Biosciences (UK)
Pablo Cironi, Caixa Capital Risc (ES)

12h00 |

Masterclass: How to raise capital from VCs: the winning way
Dirk Kersten, General Partner at Forbion (NL).

12h20 |

Buffet Lunch and Networking

13h30 |

Keynote Session: Lymphact: how we went from the lab to a successful exit.
Prof. Bruno Silva Santos, Institute of Molecular Medicine, University of Lisbon, Founder

13h50 |

Panel – What do corporates and startups need from each other?
Moderated by David Cristina, Fosun Healthcare (UK)

Richard Davis, Johnson & Johnson Innovation (UK)
Khatereh Ahmadi, Merck Sharp & Dohme (UK)
Jorge Santos da Silva, McKinsey & Co (CH)
Gonçalo Andrade, Nanoform (FI)

14h30 |

Digital Health Time – Presentations by Performetric and Mediceus

15h10 |

Coffee Break and Networking

15h40 |

Medtech Time: Presentations by Adapttech, Delox and GlyCardial Diagnostics

Jury Members:
David Malta, Vesalius (LU)
João Ribas, Novo Holdings (DK)
José Mesa, Alta Life Sciences (ES)
Peter Dines, Mercia Asset Management PLC (UK)

16h30 |

Closing
Peter Villax, Chairman of Hovione Capital

16h40 |

Drinks & Networking

18h00 |

Event Closing

Meet Health Startup Day Startups

logo_name-6e6bbaeae309ccd06dedc6203f71912f214d51db5d3419d54a37a07967242272

The speakers

Carlos

Moedas

Carlos Moedas is a Portuguese civil engineer, economist and politician. Between 2011 and 2014 he was appointed Assistant Secretary of State in the XIX Constitutional Government of Portugal. Since November 1st Moedas is European Commissioner for Research, Science and Innovation.

Peter

Dines

Peter joined Mercia Asset Management PLC (UK) in 2015 as Head of Life Sciences & Biosciences. He is currently responsible for investing in new companies in the life sciences sector, with over 20 years’ experience. In addition became Chief Operating Officer in 2018.

Dirk

Kersten

Dirk Kersten is a General Partner at Forbion and focuses primarily on new investments. Dirk was previously a Partner at Gilde Healthcare, where he led their Boston/US operations.

José António

Mesa

Jose Mesa is a Partner at Alta Life Sciences where he invests in drug development and medical devices. Jose was previously Investment Director at Caixa Capital Risc where he lead analysis, negotiation and structuring of investments in life sciences companies.

Jorge

Santos da Silva

Jorge Santos da Silva is a Partner at McKinsey where he leads the Biotech and Biosimilars practice. His areas of expertise are commercial and marketing strategy, launch and M&A. He previously had a successful academic career in science, especially in neurology/neuroscience.

João

Ribas

João Ribas joined Novo Seeds in 2018 as an Investment Associate. Previously, he was an analyst at M Ventures. Among other activities, he started several new ventures in the USA and Europe.

Jonathan

Tobin

Jonathan Tobin is an Investment Director at Arix Bioscience where he specializes in biotechnology investments. He currently sits on the board of Artios Pharma, Atox Bio and Mitoconix Bio.

Khatereh

Ahmadi

Khatereh is Executive Director and Oncology Search and Evaluation Lead at Merck Sharp & Dohme in London. Previously, Khatereh advised several Biotechs and led several M&A and licensing deals.

Giovanni

Mariggi

Giovanni is a Partner at Medicxi and has been with the firm since its inception in 2016. Prior to Medicxi, Giovanni was a Principal at Index Ventures for four years, having joined in 2012.

Pablo

Cironi

Pablo is the Director of Life Science Investment Funds at Caixa Capital Risc. He currently serves on the Board of Medlumics, Aelix Therapeutics, Minoryx Therapeutics, iProteos, Proteodesign and Sanifit.

David

Malta

David Braga Malta is a Venture Partner at Vesalius Biocapital. He previously founded NeurIMM, Cell2B and BoostPharma, where he serves(ed) as a manager. He was previously a member of Caixa Capital’s venture capital team.

Marco

Fernandes

Marco Fernandes is currently CEO of PME Investimentos, leading the new 200M Coinvestment Fund and Social Innovation Fund management teams. Previously was Director of DNA Cascais and CEO of Portugal Ventures

Daniela

Couto

Daniela Couto is a Principal at Biogeneration Ventures. Daniela is the managing director of Staten Biotech and serves on the board of Catalym. Daniela previously was CEO at Cell2B, a life sciences company that she co-founded dedicated to treat immune and inflammatory diseases.

Daniela

Seixas

MD, PhD, MBA, co-founder & CEO of Tonic App, a digital health startup. Built her clinical and academic career for more than 17 years before joining this venture.

Bruno

Silva-Santos

Prof. Bruno Silva-Santos is an Associate Professor at the Faculty of Medicine of the University of Lisbon and Principal Investigator at João Lobo Antunes Molecular Institute of Medicine in Lisbon.

Rick

Davis

Rick is Senior Director, New Ventures and Transactions, Oncology at Johnson & Johnson Innovation in London. In this role, Rick leverages his experience and knowledge of the scientific and biotech landscape to identify and evaluate external opportunities and deliver transformative innovation into the pipeline.

David

Cristina

Executive Director at Fosun International, a leading Chinese conglomerate, where he currently leads the Healthcare Investment team for Europe. He has over 10 years of experience in venture creation, VC and PE experience across US, EU and China. He was on the board of Lymphact, Immunethep and Tonic App.

Gonçalo

Andrade

Chief of Business Operations at Nanoform. Gonçalo is a Biochemist by training and has over 20 years’ experience in the pharmaceutical and venture capital industries.

Peter

Villax

Peter Villax is currently Chairman of Hovione Capital, a VC firm focused on investing in life sciences’ projects across Europe. Peter is the President of the Portuguese Family Business Association and Board Member of the European Family Businesses Federation.

Ricardo

Perdigão Henriques

Ricardo Perdigão Henriques is the CEO of Hovione Capital, a healthcare-specialized VC fund based in Portugal investing in early-stage life sciences projects across Europe.

Get to know our partners

Interested?

View the agenda | Buy Tickets

LISBON INVESTOR CONFERENCE

November 7th and 8th

Agenda

GROWTH DAY

09h00 |

Registration, Networking and Welcome Coffee

09h30 |

Opening time Peter Villax, Conference Host and President of the Portuguese Family Business Association Marcos Lagoa, Conference Chairman

09h40 |

Keynote Session: The importance of capital markets for Portugal. Minister of the Economy (tbc)

10h00 |

Masterclass: Financing alternatives and the Advisory Role José Lemos, Partner, Clearwater International Rita Barosa, CEO, Alantra Portugal

10h30 |

Coffee Break and Networking

11h00 |

Debt – The Classic Alternative Case Study: Alantra Private Debt

11h45 |

Mezzanine – Boosting Growth Gonçalo Mendes e Daniel Viana, Oxy Capital Case Study – Respol

12h20 |

Private Equity – New shareholders to Growth Marco Lebre, Partner, Crest Capital Partners João Coelho Borges, Partner, Magnum Capital Industrial Partners Case Study: Solzaima with Nuno Cerqueira

13h30 |

Buffet Lunch and Networking

14h00 |

Taxes – The Eternal Variable Michael A. Santos, KPMG

14h45 |

Masterclass: Corporate Governance – Governing the Family and the Business Duarte Pitta Ferraz, Nova SBE João Talone, Partner Magnum Capital Industrial Partners

15h15 |

Round Table: Corporate Governance Moderator: Duarte Pitta Ferraz João Talone, Magnum Capital Industrial Partners

15h30 |

Coffee Break and Networking

15h45 |

Interview with Diane Villax, Hovione By Alexandra Abreu Loureiro, partner of the reputational consultant Brunswick Group

16h30 |

Closure: Conference Conclusions by Peter Villax

16h40 |

Drinks & Networking

19h40 |

Lisbon Investor Conference Dinner at Kais Restaurant Keynote Speaker: Garrett McNamara, surfer of the great wave of the Nazareth Cannon. Ingredients for success: courage, preparation and teamwork.

The speakers

Interested?

Agenda

HEALTH STARTUP DAY

08h00 |

Registration, Networking and Welcome Coffee

09h00 |

Opening of the Conference Welcome Remarks – Peter Villax, Chairman Hovione Capital Conference Outline – Ricardo P. Henriques, Conference Chairman & CEO Hovione Capital

09h20 |

Keynote Session: Why this is a great time to invest in life sciences in Portugal. Carlos Moedas, European Commissioner for Research, Science and Innovation (tbc)

09h40 |

Therapeutics Time: Presentations by SolasCure, Immunethep and CellmAbs

10h30 |

Coffee Break and Networking

11h00 |

Therapeutics Time: Presentations by BSIM Therapeutics and Asgard Therapeutics Jury Members Lev Osherovich, Versant Ventures (CH) Daniela Couto, Biogeneration (NL) Giovanni Mariggi, Medicxi (UK) Jonathan Tobin, Arix Biosciences (UK) Pablo Cironi, Caixa Capital Risc (ES)

12h00 |

Masterclass: How to raise capital from VCs: the winning way Dirk Kersten, General Partner at Forbion (NL).

12h20 |

Buffet Lunch and Networking

13h30 |

Keynote Session: Lymphact: how we went from the lab to a successful exit. Prof. Bruno Silva Santos, Institute of Molecular Medicine, University of Lisbon, Founder

13h50 |

Panel – What do corporates and startups need from each other? Moderated by David Cristina, Fosun Healthcare (UK) Richard Davis, Johnson & Johnson Innovation (UK) Khatereh Ahmadi, Merck Sharp & Dohme (UK) Jorge Santos da Silva, McKinsey & Co (CH) Gonçalo Andrade, Nanoform (FI)

14h30 |

Digital Health Time – Presentations by Performetric and Mediceus

15h10 |

Coffee Break and Networking

15h40 |

Medtech Time: Presentations by Adapttech, Delox and GlyCardial Diagnostics Jury Members: David Malta, Vesalius (LU) João Ribas, Novo Holdings (DK) José Mesa, Alta Life Sciences (ES) Peter Dines, Mercia Asset Management PLC (UK)

16h30 |

Closing Peter Villax, Chairman of Hovione Capital

16h40 |

Drinks & Networking

18h00 |

Event Closing

The speakers

Ahmadi

Seixas

Andrade

Interested?

Opening time
Peter Villax, Conference Host and President of the Portuguese Family Business Association
Marcos Lagoa, Conference Chairman

Keynote Session: The importance of capital markets for Portugal.
Minister of the Economy (tbc)

Masterclass: Financing alternatives and the Advisory Role
José Lemos, Partner, Clearwater International
Rita Barosa, CEO, Alantra Portugal

Debt – The Classic Alternative
Case Study: Alantra Private Debt

Mezzanine – Boosting Growth
Gonçalo Mendes e Daniel Viana, Oxy Capital
Case Study – Respol

Private Equity – New shareholders to Growth
Marco Lebre, Partner, Crest Capital Partners
João Coelho Borges, Partner, Magnum Capital Industrial Partners

Case Study: Solzaima with Nuno Cerqueira

Taxes – The Eternal Variable
Michael A. Santos, KPMG

Masterclass: Corporate Governance – Governing the Family and the Business
Duarte Pitta Ferraz, Nova SBE
João Talone, Partner Magnum Capital Industrial Partners

Round Table: Corporate Governance

Moderator: Duarte Pitta Ferraz

João Talone, Magnum Capital Industrial Partners

Interview with Diane Villax, Hovione
By Alexandra Abreu Loureiro, partner of the reputational consultant Brunswick Group

Closure: Conference
Conclusions by Peter Villax

Lisbon Investor Conference Dinner at Kais Restaurant
Keynote Speaker: Garrett McNamara, surfer of the great wave of the Nazareth Cannon.
Ingredients for success: courage, preparation and teamwork.

Opening of the Conference
Welcome Remarks – Peter Villax, Chairman Hovione Capital
Conference Outline – Ricardo P. Henriques, Conference Chairman & CEO Hovione Capital

Keynote Session: Why this is a great time to invest in life sciences in Portugal.
Carlos Moedas, European Commissioner for Research, Science and Innovation (tbc)

Therapeutics Time: Presentations by BSIM Therapeutics and Asgard Therapeutics

Jury Members
Lev Osherovich, Versant Ventures (CH)
Daniela Couto, Biogeneration (NL)
Giovanni Mariggi, Medicxi (UK)
Jonathan Tobin, Arix Biosciences (UK)
Pablo Cironi, Caixa Capital Risc (ES)

Masterclass: How to raise capital from VCs: the winning way
Dirk Kersten, General Partner at Forbion (NL).

Keynote Session: Lymphact: how we went from the lab to a successful exit.
Prof. Bruno Silva Santos, Institute of Molecular Medicine, University of Lisbon, Founder

Panel – What do corporates and startups need from each other?
Moderated by David Cristina, Fosun Healthcare (UK)

Richard Davis, Johnson & Johnson Innovation (UK)
Khatereh Ahmadi, Merck Sharp & Dohme (UK)
Jorge Santos da Silva, McKinsey & Co (CH)
Gonçalo Andrade, Nanoform (FI)

Medtech Time: Presentations by Adapttech, Delox and GlyCardial Diagnostics

Jury Members:
David Malta, Vesalius (LU)
João Ribas, Novo Holdings (DK)
José Mesa, Alta Life Sciences (ES)
Peter Dines, Mercia Asset Management PLC (UK)

Closing
Peter Villax, Chairman of Hovione Capital